| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/03/2013 | US8524700 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 09/03/2013 | US8524446 Method for detecting adeno-associated virus |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | CA2723131C Compositions comprising galactomannan and a process thereof |
| 09/03/2013 | CA2707767C Biologically active peptides |
| 09/03/2013 | CA2595182C Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 09/03/2013 | CA2565029C Immediate release pharmaceutical tablets with height greater than width |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126776A1 Nanostructures for treating cancers and other conditions |
| 08/29/2013 | WO2013125732A1 Aromatic ring compound |
| 08/29/2013 | WO2013124463A1 Relaxin for treating patients afflicted of impaired glucose tolerance |
| 08/29/2013 | WO2013124413A1 Thiadiazolidinediones as gsk-3 inhibitors |
| 08/29/2013 | WO2013124381A1 Peltatin for use in the treatment of metabolic disorders |
| 08/29/2013 | WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | WO2013124158A1 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | US20130225622 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt |
| 08/29/2013 | US20130224320 Process to improve feed efficiency and carcass characteristics of animals |
| 08/28/2013 | EP2630964A1 Method and medicament for treating patients in risk of prediabetes and type-2 diabetes |
| 08/28/2013 | EP2630493A2 Antigen-specific, tolerance-inducing microparticles and uses thereof |
| 08/28/2013 | EP2630124A1 Tetrahydroquinoline derivatives used as ampk activators |
| 08/28/2013 | EP2629784A1 A novel herbal oil for controlling blood sugar without risk of hypoglycemea |
| 08/28/2013 | EP2629776A2 Compounds, compositions and methods useful for cholesterol mobilisation |
| 08/28/2013 | EP2629774A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2629773A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2629771A1 Use of pi3k inibitors for the treatment of obesity, steatosis and ageing |
| 08/28/2013 | EP2629769A1 Cysteine and food intake |
| 08/28/2013 | EP2629758A2 Metal ion nanoclusters |
| 08/28/2013 | EP2629632A1 Formulation comprising arginine, use and preparation thereof |
| 08/28/2013 | CN103270018A Calcium-sensing receptor-active compounds |
| 08/28/2013 | CN103269700A Picropodophyllin polymorphs b or c for use in cancer therapy |
| 08/28/2013 | CN103269697A Cysteine and food intake |
| 08/28/2013 | CN103266012A Special tea oil for postpartum woman |
| 08/28/2013 | CN103266009A High-purity walnut alpha-linolenic acid as well as preparation method and applications thereof |
| 08/28/2013 | CN103265636A Novel peptide with hypoglycemic effect |
| 08/28/2013 | CN103265515A Sibiraea angustata acid a, stereoisomer and applications thereof |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN103265476A Azasugar quaternary ammonium salt compound and preparation method and application thereof |
| 08/28/2013 | CN103263660A Earthworm protein for reducing blood sugar and blood pressure and eliminating diabetic complications and application pf earthworm protein |
| 08/28/2013 | CN103263628A Traditional Chinese medicine for treating diabetes |
| 08/28/2013 | CN103263606A Traditional Chinese medicine composition for treating diabetic foot by foot bath nursing and application of traditional Chinese medicine composition |
| 08/28/2013 | CN103263595A Traditional Chinese medicine composition for treating diabetes |
| 08/28/2013 | CN103263582A Weight losing prescription |
| 08/28/2013 | CN103263581A Shuangshen capsule for reducing blood sugar |
| 08/28/2013 | CN103263580A Traditional Chinese medicine composition for treating diabetes |
| 08/28/2013 | CN103263568A Traditional Chinese medicine composition for preventing and treating constipation, ozostomia and adiposity, and preparation method thereof |
| 08/28/2013 | CN103263549A Chinese medicine fumigating and washing agent for treating diabetic feet |
| 08/28/2013 | CN103263497A Blood sugar reduction agent and preparation method thereof |
| 08/28/2013 | CN103263486A Application of paeoniae radix extract with hypoglycemic activity |
| 08/28/2013 | CN103263484A Fermentation method and fermentation product of tartary buckwheat bran |
| 08/28/2013 | CN103263453A Traditional Chinese medicine preparation for treatment of hyperlipidemia, hyperglycemia, high blood viscosity and hypertension and preparation method thereof |
| 08/28/2013 | CN103263449A Mongolian medicine for treatment of hyperglycemia and diabetes |
| 08/28/2013 | CN103263448A Fermentation bacteria used for fermentation pretreatment to improve extraction of Ginkgo biloba L. leaf flavone and application |
| 08/28/2013 | CN103263440A Method for extracting and preparing homology mesenchymal stem cell injection from placenta and umbilical cord |
| 08/28/2013 | CN103263439A CD34 stem cell-related methods and compositions |
| 08/28/2013 | CN103263436A Disodium adenosine triphosphate and magnesium chloride composition for injection, and freeze-dried powder injection and preparation method thereof |
| 08/28/2013 | CN103263432A Traditional Chinese medicine monomer compound preparation for preventing and treating diabetic heart injuries and preparation method thereof |
| 08/28/2013 | CN103263427A Application of neohesperidin in hyperlipidemia prevention and treatment drug preparation |
| 08/28/2013 | CN103263419A New application of pharmaceutical composition of metformin and 5-methyltetrahydrofolate |
| 08/28/2013 | CN103263408A Allicin nano liposome and preparation method and application thereof |
| 08/28/2013 | CN103263406A Use of DHA, epa or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 08/28/2013 | CN103263405A Medicinal composition for treating diabetes, and its application |
| 08/28/2013 | CN103263401A Pinenut oil pinolenic acid microcapsule and preparation method thereof |
| 08/28/2013 | CN103263020A Preparation of teenager nutrient supplements |
| 08/28/2013 | CN102860390B Mulberry leaf weight-reducing tea and method for preparing same |
| 08/28/2013 | CN102697910B Chinese medicinal extract dripping pill for treating diabetes and hyperlipidemia |
| 08/28/2013 | CN102579587B Traditional Chinese medicine composition for preventing and treating diabetes and complications thereof |
| 08/28/2013 | CN102579442B Compound preparation containing benidipine hydrochloride and atorvastatin calcium and application for compound preparation |
| 08/28/2013 | CN102492051B Polygonatum odoratum deep processing and comprehensive utilization process |
| 08/28/2013 | CN102397535B Insulin crystal microsphere, insulin crystal microsphere suspension, and preparation method thereof |
| 08/28/2013 | CN102309705B Medicine for reducing serum uric acid, preparation method thereof and purpose thereof |
| 08/28/2013 | CN102286396B Compound microorganism preparation with lactobacillus and preparation method thereof |
| 08/28/2013 | CN102260266B Pyrazolo[3,4-d]pyrimidone compounds and application thereof in preparation of phosphodiesterase IX inhibitor |
| 08/28/2013 | CN102219849B Method for separating and purifying exenatide on large scale |
| 08/28/2013 | CN102204951B Method for extracting active components from licorice |
| 08/28/2013 | CN102070726B Method for safely extracting cordyceps sinensis polysaccharide |
| 08/28/2013 | CN101970458B Novel gamma-secretase inhibitor |
| 08/28/2013 | CN101904946B Full-effect tea-lavender fat-suppression formulation with natural activity |
| 08/28/2013 | CN101787016B Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 08/28/2013 | CN101522707B 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 08/28/2013 | CN101474299B Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes |
| 08/28/2013 | CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 08/28/2013 | CN101248049B 咪唑类lxr调节剂 Imidazole lxr modifier |
| 08/28/2013 | CN101248048B Imidazole based LXR modulators |
| 08/28/2013 | CN101134058B Health products having blood fat and blood pressure reducing functions and manufacturing method thereof |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518997 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518936 Method for preparing acid addition salts of polyacidic basic compounds |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2649741C Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/27/2013 | CA2375980C Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 08/22/2013 | WO2013123444A1 Sulfonyl compounds that interact with glucokinase regulatory protein |
| 08/22/2013 | WO2013123335A1 Peripherally restricted diphenyl purine derivatives |
| 08/22/2013 | WO2013123218A1 Selective estrogen receptor modulators with short half-lives and uses thereof |
| 08/22/2013 | WO2013122920A1 Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | WO2013122622A1 A method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 08/22/2013 | WO2013120935A1 Pharmaceutical compositions for combination therapy |
| 08/22/2013 | WO2013120921A1 Novel pyrrolidine derivatives |